GoodRx Holdings, Inc. Operating Income Loss

• GoodRx Holdings, Inc. showed an increase of +32.9% in Operating Income Loss from 2024 to 2025.
• This data is from GoodRx Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), GoodRx Holdings, Inc.'s Operating Income Loss has grown by 13.3%.
• Historical annual values: Fiscal year 2025: $87.49 million | Fiscal year 2024: $65.85 million | Fiscal year 2023: -$27.01 million | Fiscal year 2022: $1.74 million | Fiscal year 2021: $13.41 million | Fiscal year 2020: -$275.72 million | Fiscal year 2019: $139.68 million | Fiscal year 2018: $77.25 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026